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Abstract
The heart generates and propagates action potentials through synchronized activation of ion channels allowing inward Na
+
and Ca
2+ and outward K
+ currents. There are a number of K
+ channel types expressed in the heart that play key roles in
regulating the cardiac cycle. Large conductance calcium-activated potassium (BK) ion channels are not thought to be
directly involved in heart function. Here we present evidence that heart rate can be significantly reduced by inhibiting the
activity of BK channels. Agents that specifically inhibit BK channel activity, including paxilline and lolitrem B, slowed heart
rate in conscious wild-type mice by 30% and 42%, respectively. Heart rate of BK channel knock-out mice (Kcnma1
2/2) was
not affected by these BK channel inhibitors, suggesting that the changes to heart rate were specifically mediated through
BK channels. The possibility that these effects were mediated through BK channels peripheral to the heart was ruled out
with experiments using isolated, perfused rat hearts, which showed a significant reduction in heart rate when treated with
the BK channel inhibitors paxilline (1 mM), lolitrem B (1 mM), and iberiotoxin (0.23 mM), of 34%, 60%, and 42%, respectively.
Furthermore, paxilline was shown to decrease heart rate in a dose-dependent manner. These results implicate BK channels
located in the heart to be directly involved in the regulation of heart rate.
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Introduction
Large conductance calcium-activated potassium (BK) ion
channels are expressed in many tissues that exhibit diverse
physiological characteristics. BK channels are activated by
intracellular calcium and depolarizing membrane voltages. BK
channels are highly expressed in smooth muscle where they have
been shown to affect myogenic tone [1] and therefore regulate
blood pressure [2], cerebrovascular circulation [3], erectile
function [4], and urinary bladder function [5,6]. They are also
prevalent in the brain where they have important roles in the
regulation of neuronal circuits in the hippocampus [7], in motor
function and cerebellum [5,8,9], and in circadian rhythm and the
hypothalamus [10]. BK channels have also been found to have
roles in hearing [11,12], kidney filtration [13], colonic K
+
secretion [14,15], and immune function [16]. BK-type channels
are thought to be present in the inner mitochondrial membrane of
cardiac myocytes and protect against cardiac ischemia [17].
The BK channel a-subunit assembles as a homotetramer to
form the channel pore [18,19]. It may associate with an accessory
b subunit(s) of which four have been identified, b1, b2, b3 and b4,
that have restricted expression patterns and modify channel
activity by altering sensitivity to voltage and calcium, or affect
inactivation (for review see [20]). The b1 subunit is most highly
expressed in smooth muscle, b2 in the ovary, b3 in the testis, and
b4 subunit in neural tissue [21,22], although lower levels exist in
other tissues, and some b subunits appear to coexist [22,23].
The molecular function of BK channels has been well studied
and has been greatly aided by the use of BK channel inhibitors, for
example, tetraethylammonium (TEA), the peptide inhibitors
charybdotoxin and iberiotoxin, and the fungal alkaloids paxilline
and lolitrem B. Iberiotoxin is the most specific BK channel
inhibitor yet characterized [24,25,26], but it is of low activity
against channels containing the b4 subunit [27,28], and is
membrane-impermeable, limiting its use in whole animal
experiments. The membrane-permeable fungal alkaloid, paxilline
has become widely used as a BK channel inhibitor in molecular
physiology due to its ability to block BK channels complexed with
b4 subunits [29]. More recently, however, another fungal alkaloid,
lolitrem B has been shown to be five-times more potent at
inhibiting BK channels in comparison to paxilline [30,9]. A
further seven lolitrem compounds have also been shown to be BK
channel inhibitors [31]. Lolitrem B is the causative agent of
ryegrass staggers, a nervous disorder of animals that graze
perennial ryegrass infected with the endophytic fungi Neotyphodium
lolii. Using a mouse model of ryegrass staggers, we have shown that
lolitrem B produces ataxia and tremors by inhibiting BK channels
[9]. In addition to lolitrem B, this endophyte-grass symbiosis also
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only minor structural changes have a dramatic effect on
tremorgenicity [32,33,34].
As part of a study on the physiological effects of lolitrem B and
paxilline in mice we monitored cardiovascular function and
observed unexpected responses to these compounds. Since BK
channels expressed in smooth muscle regulate vascular tone [1,2],
it may be anticipated that BK channel inhibitors might affect
blood pressure when administered to mice. Contrary to this,
however, we found no change in blood pressure but observed a
dramatic effect on heart rate. This effect was surprising since there
was no published evidence of a direct role for BK channels in the
regulation of heart rate. However, we note that there are only a
few reports in the literature on the effects of BK channel inhibitors
in whole animals [35,36], and none designed to study their effects
on heart rate.
Although heart beat initiation and propagation involves the
interplay among many ionic currents from a range of ion channels,
electrophysiological studies of BK channels in the cardiac muscle
plasma membrane show no evidence of BK channel involvement,
and given the low level of BK channels expressed in the whole
heart, a role of these channels in heart function has previously
been overlooked [37,38,39,40,41]. Heart rate is initiated in the
sinoatrial (SA) node pacemaker and is modulated by autonomic
inputs: parasympathetic cholinergic neurons decrease heart rate
via the vagus nerve, and sympathetic adrenergic neurons increase
heart rate. Functional BK channels are present in these autonomic
neurons and contribute to action potential repolarisation and
after-hyperpolarisation currents [42,43]. Although BK channels
are present in Purkinje fibres of the cardiac ventricle conduction
system [44], any effects from this location would be downstream of
that from heart beat initiation and would therefore not be
expected to alter rate. Although BK channels have also been
identified in the inner mitochondrial membrane of myocytes [17],
it is unlikely that their action at this site would influence
pacemaker function.
The aim of this study was to investigate the role of BK channels
in cardiovascular function. The BK channel inhibitors lolitrem B,
paxilline, and iberiotoxin were used as pharmacological tools to
investigate effects of loss of BK channel function on blood pressure
and heart rate in wild-type mice and results compared with that in
BK channel knock-out mice. To determine whether the BK
channel antagonist effects were cardioselective or worked at
peripheral sites, we also investigated BK channel function in an
isolated, perfused rat heart preparation.
Materials and Methods
Animals
Mice. BK channel–null (Kcnma1
2/2) mice had an FVB
background, and their wild-type littermates were used as
controls [5]. Heterozygous mice were used as breeding pairs,
and all mice were genotyped by PCR. The b1- and b4-subunit-
null (Kcnmb1
2/2 and Kcnmb1/b4
2/2) mice [2,7] had a mixed
C57BL/6J background, and C57BL/6J wild-type mice were used
as strain controls. Male and female mice aged between 2 and 24
months were used, and treatment groups were matched for age
and sex.
Rats. Male and female Sprague Dawley rats between the ages
of 3 and 4 months were used for Langendorff isolated heart
experiments. Animals were asphyxiated by carbon dioxide
inhalation and decapitated prior to removal of the heart for
perfusion.
Compounds
Lolitrem B and lolitrem E were extracted and purified from
perennial ryegrass infected with N. lolii as previously described
[32]. Lolitrem E acetate was synthesized from lolitrem E [45] and
31-epilolitrem B from lolitrem B [34]. Paxilline was produced by
Penicillium paxilli cultures as described previously [46]. rIberiotoxin
was purchased from Alomone Labs, Product # RTI-400
(Jerusalem, Israel).
Ethics Approval
Animal manipulations were approved by the AgResearch
Ruakura Animal Ethics Committee (NZ), Victoria University
Animal Ethics Committee (NZ) (permission given to euthanize
animals for tissue harvest) and the Stanford University Animal
Care and Use Committees (USA).
Blood Pressure Analysis in Mice
Mean blood pressure and heart rate were measured in conscious
animals with a blood pressure analysis system utilizing a tail-cuff
method (BP-2000, Visitech Systems). Mice were trained for 3
consecutive days in the pre-warmed (30uC) device to avoid a stress-
induced increase in blood pressure. For each blood pressure
determination, 10 measurements were obtained and averaged per
mouse.
Langendorff Preparation – Isolated, Perfused Rat Heart
The use of the Langendorff rat heart preparation has recently been
reviewed [47]. To set up a standard, non-working heart preparation, a
rat was partially asphyxiated with CO2 then decapitated and the heart
removed following injection of 30 ml heparin (16 U/ml saline) into the
inferior vena cava. The aorta was cannulated, and the coronary
circulation perfused retrogradely by gravity feed (78 cm height) with
37uC oxygenated (95% O2,5 %C O 2 – Carbogen, BOC gases, Lower
Hutt, NZ) Krebs-Henseleit solution (118.5 mM NaCl, 25.0 mM
NaHCO3,4 . 7 m MK C l ,1 . 2 m MM g S O 4,1 . 2 m MK H 2PO4,
11.0 mM glucose, 1.8 mM CaCl2,p H 7 . 4 ) .AP o w e r L a bs y s t e m
(ADInstruments, Model 8SP, Dunedin, NZ) was used to monitor
cardiac function with inputs supplied from a pressure transducer
connected in-line with the aortic cannula (Medstad, model no. 60–800)
and three electrocardiographic leads attached to the apex of the heart
(two leads) and lower left ventricle (one lead) to measure the ECG.
Immediately after perfusion commenced, the coronary vessels cleared
of blood, and the heart began to beat strongly within a few seconds.
Heart rate and aortic pressures were continuously recorded, beginning
with an equilibration period of at least 40 min, and analyzed using
Chart5 for Windows (v5.2.2, ADInstruments). Heart temperature was
continuously monitored with a scanning tele-thermometer fitted with a
needle thermistor (Yellow Springs Instrument Co., Model 47, Yellow
Springs, OH) and temperature was maintained at 3760.5uC
throughout the experiment. Coronary flow was measured by collecting
the perfusate outflow over time.
Drug Delivery
Whole mouse experiments: Toxins were administered to mice
by intraperitoneal injection as a solution in 9:1 (v/v) DMSO-water
(50 ml).
Isolated heart: Drugs were administered to the isolated heart by
intracoronary infusion through the aortic cannula using a syringe
pump (KDScientific,modelKDS120).The druginfusionspeedwas
set at 1 ml/min, about 10% of normal coronary flow rate for an
isolated rat heart. To control for the diluent needed to solubilize
lolitrem B and paxilline, 0.1% DMSO in Krebs-Henseleit buffer
was infused into the aortic cannula for 12 min, followed by 30 min
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0.23 mM rIberiotoxin, or 1–10 mM paxilline, as described above.
Dose-response experiments were not performed for rIberiotoxin or
lolitrem B due to the high cost of these compounds.
Statistical Analyses
Results where n$3 are expressed as means. Error bars in each
figure show 6 S.E.M. Treatments were compared using a least
significant post hoc test after analysis of variance except when
there were four measurements made within each mouse in which
case a repeated measures one-way analysis of variance followed by
Tukey-Kramer multiple comparisons post hoc test was used.
Between animal differences were accounted for in all tests. A
paired Student’s t-test using was also used. InStat version 3.0b
(GraphPad Software, Inc) and Genstat version 11.1 (VSN
International Limited, Hemel Hempstead, UK) software was used.
Results
Inhibition of BK Channels In Vivo Has No Effect on Blood
Pressure but Decreases Heart Rate
In order to investigate the contribution of BK channels to
cardiovascular function, effects of two indole diterpene BK
channel inhibitors, lolitrem B and paxilline, were examined. Both
compounds were used because of differences in their potencies and
duration of effect in vivo [48,9]. Dose rates of 4 mg/kg lolitrem B
and 8 mg/kg paxilline were chosen since these levels produce
significant motor function deficits in wild-type mice [9]. The
compounds were administered to mice and their effects on blood
pressure and heart rate measured.
Both lolitrem B and paxilline were found to have no effect on
mean blood pressure in wild-type mice (Fig. 1A & B), but both
inhibitors induced a significant decrease in heart rate (Fig. 1C &
D). In wild-type mice treated with paxilline, heart rate was
decreased by 31% 30 min after toxin administration, an effect that
lasted for 3 h, followed by a gradual recovery to baseline levels by
30 h (Fig 1D). In mice dosed with lolitrem B, heart rate was
decreased by 42% 2 h after treatment which persisted for a further
8 h, followed by a slow recovery over 4 days (Fig 1C). The
difference in time-course observed for paxilline and lolitrem B is
consistent with that observed for the motor function effects [9].
These results show that BK channel inhibitors significantly
decrease heart rate under conditions of normal autonomic tone.
To determine whether the observed heart rate effects also
occurred with structurally related compounds of varying potency,
we extended the study to include a further two lolitrem
Figure 1. The effects of lolitrem B and paxilline on blood pressure and heart rate in Kcnma1
2/2 mice and wild-type littermates. Inhibitors
were added immediately after the control reading at time zero as indicated by the arrow. Mean blood pressure following treatment with (A) 4 mg/kg
lolitrem B, or (B) 8 mg/kg paxilline. Heart rate following treatment with (C) lolitrem B, or (D) paxilline. Data are mean 6 S.E.M. for n=4 in each
treatment group. Significance was tested using Tukey-Kramer post hoc test after a repeated measures analysis of variance. Asterisks indicate the
significance of each treatment in wild-type mice compared with the pre-drug control at time=0. *, P,0.05; **, P,0.01; ***, P,0.001.
doi:10.1371/journal.pone.0008698.g001
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is less potent as a BK channel inhibitor (IC50=50 nM) in
comparison to paxilline (IC50=22 nM) and lolitrem B
(IC50=4 nM) [31]. Lolitrem E acetate is the most potent BK
channel inhibitor of this structural class (IC50=2.6 nM) [31], but
induces only low intensity tremors at high concentrations in mice
[32]. The effects of these non-tremorgenic BK channel inhibitors
are shown in Figure S1. Lolitrem E acetate (4 mg/kg) decreased
heart rate by 30% but had no effect on blood pressure. 31-
epilolitrem B (20 mg/kg) had no effect on heart rate or blood
pressure. Since lolitrem B was the most potent lolitrem to affect
heart rate, it was used in subsequent experiments. Paxilline was
also used because of its relatively short onset and rapid recovery.
Kcnma1
2/2 Mice Are Insensitive to Cardiovascular Effects
of BK Channel Inhibitors
To determine whether the heart rate decrease induced by
lolitrem B and paxilline is specifically due to BK channel
inhibition, we examined the effects of both compounds on mice
with a targeted deletion in the gene encoding the pore-forming
unit of the BK channel (Kcnma1
2/2). Lolitrem B had no effect on
blood pressure or heart rate in Kcnma1
2/2 mice (Fig 1A & C), and
paxilline was similarly without effect (Fig 1B &1D). A drug vehicle
control of DMSO:water (9:1) was administered which showed no
change in blood pressure or heart rate in either wild-type or
Kcnma1
2/2 mice. These results indicate that the BK channel a
subunit is required for lolitrem B and paxilline to reduce heart rate
in mice and provide further support for a specific role of BK
channels in heart rate control.
Paxilline-Mediated Effects on Heart Rate Do Not Involve
the b1o rb4 Subunits
Given the functional heterogeneity that is conferred on BK
channels by the accessory beta subunits, we investigated whether
b1 and b4 subunits are required for the cardiovascular effects of
the BK channel inhibitors. The b1 subunit is highly expressed in
blood vessels, including the coronary arterioles, and therefore it
was considered that its role in blood pressure regulation might
indirectly affect heart rate [49]. A possible role for the b4 subunit
in regulation of heart rate was investigated because it is expressed
in neural tissue and is likely to be present in the neurons that
innervate the heart [22]. An effect that requires the b4 subunit
would indicate that the channels containing this subunit are
involved in regulation of heart rate, and that the effect is likely of
neural origin.
To determine whether the b1o rb4 subunits are involved in the
BK channel-mediated chronotropic effects, b1 and b1/b4 knock-
out mice (Kcnmb1
2/2 and Kcnmb1b4
2/2, respectively) were treated
with 8 mg/kg paxilline and heart rate and blood pressure
monitored. Paxilline had no effect on the blood pressure of
Kcnmb1
2/2 and Kcnmb1b4
2/2 knockout mice, as seen in wild-type
controls (Fig. 2B). However, a substantial decrease in heart rate
was detected in response to paxilline in Kcnmb1
2/2 and
Kcnmb1b4
2/2 knockout mice, similar to that seen in wild-type
mice. This suggests that the BK channel b1 and b4 subunits are
not required for paxilline to decrease heart rate.
Inhibition of BK Channels in the Isolated, Perfused Rat
Heart Decreases Heart Rate
To determine whether the effects on heart rate were mediated
by a direct effect on the heart or through other secondary
cardiovascular effects, experiments were performed using isolated,
perfused rat hearts. Each heart was monitored for a minimum of
30 min, during which time a vehicle control was perfused for
10 min, prior to adding the BK channel inhibitor. The perfusion
fluid contained #0.1% DMSO to help solubilize the indole
diterpenoid compounds, as used in previous in vitro experiments
[30,9,31]. Paxilline (1 mM) infusion over 10 min induced a
decrease in heart rate of 34% at 5 min, an effect which lasted
for a total of 20 min. Heart rate then returned to baseline levels
over the next 30 min (Fig. 3A). Lolitrem B was also tested at 1 mM
and was found to decrease heart rate by 60% (recording not
shown). Lolitrem B had a long latency of 90–120 min before heart
rate began to decrease, and recovery to baseline levels was not
observed even after a further 60 min of drug-free perfusion. This
extended the time beyond the viable life-span of the preparation,
and, therefore, longer recovery experiments were not pursued.
To determine the maximum level of heart rate decrease that
could be induced by inhibition of BK channels, increasing
concentrations of paxilline were tested using a new heart for each
trial at each concentration. Paxilline concentrations of 1, 5 and
10 mM were tested which resulted in heart rate decreases of 34%,
70% and 96%, respectively (Fig. 3B).
Since paxilline showed a strong bradycardic effect in the
isolated heart, we wanted to compare this effect with another BK
channel inhibitor. Iberiotoxin (IbTX) was used and tested in a
similar manner since it is highly specific for BK channels
[24,25,26]. In initial experiments, low concentrations of IbTX
were applied to isolated hearts until a concentration was reached
that gave a heart rate decrease. This concentration (0.23 mM) was
Figure 2. Cardiovascular function in wild-type (C57 black),
Kcnmb1
2/2, Kcnmb1/b4
2/2, and Kcnma1
2/2 mice treated with
8 mg/kg paxilline (Pax). (A) Blood pressure and (B) Heart rate. ***,
P,0.001 for significant differences between pre-treated and paxilline-
treated heart rates. Significance was tested using least significant
difference post hoc test after analysis of variance. All data are mean 6
S.E.M. for n=4 in each treatment group.
doi:10.1371/journal.pone.0008698.g002
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42% over 5 min, and this recovered to the predrug level over
15 min (P,0.001) (Fig. 3C). Perfusion of a DMSO vehicle control
performed in each experiment had no effect on baseline heart rate
(Fig. 3).
Discussion
The decrease in heart rate produced by BK channel inhibitors,
paxilline and lolitrem B, in wild-type mice was unexpected since
BK channels are not thought to be present in the heart. The
observation that these compounds had no effect on heart rate in
Kcnma1
2/2 mice further implicates BK channels in this effect. The
lack of effect of the BK channel inhibitors on blood pressure, using
a non-invasive blood pressure analysis system, was supported by
preliminary results obtained using telemetry equipment in which
paxilline given to telemetrized, freely moving, wild-type mice (n =
4, data not shown) also resulted in a decrease in heart rate. These
results indicate that the decrease in heart rate is unlikely to be due
to a secondary reflex compensatory effect related to a change in
blood pressure since no immediate change in blood pressure was
detected. It is unclear why no change in blood pressure was
detected, given the contractile responses reported for BK channel
inhibitors in smooth muscle in vitro [50,51]. It is possible that this is
due to redundancy among K
+ ion channels in control of blood
pressure. The normal blood pressure in Kcnma1
2/2 mice is
consistent with that previously reported for this phenotype at rest
[52].
The finding that BK channel inhibitors also induced bradycar-
dia in isolated hearts supports the hypothesis that this effect is
mediated through a direct effect of BK channel inhibitors on
cardiac channels rather than indirectly through non-cardiac
pathways. Of the inhibitors used, paxilline is the most commonly
used in functional studies due to its membrane permeability and
selectivity for BK channels, as non-specific effects have only been
reported at high micromolar concentrations [53,54]. The use of
the highly specific BK channel inhibitor iberiotoxin [24,25,26] in
addition to lolitrem B and paxilline strengthens the hypothesis that
a BK channel is involved in the bradycardic response.
Figure 3. The effect of paxilline and iberiotoxin on heart rate in the isolated rat heart. (A) 1 mM paxilline (Pax) was added at time=40 min
and infused for 10 min, preceded by a control infusion of Krebs-Henseleit perfusion fluid with 0.1% DMSO (n=5). (B) Heart rate before, during and
after infusion at time zero of different concentrations of paxilline (1, 5 or 10 mM). The heart rate in response to paxilline is the average of the peak
responses following treatment. Toxins dissolved in Krebs-Henseleit solution were perfused through the heart for 12 min. Significance was tested
using least significant difference post hoc test after analysis of variance. (C) Heart rate of isolated, perfused rat hearts infused with 0.23 mM iberiotoxin
(IbTX) following a control infusion of Krebs-Henseleit fluid (n=5). (D) Heart rate before treatment (saline control), at peak effect following infusion of
iberiotoxin (n=5), and following recovewry. Significance was tested using a paired Student’s t-test. All data are mean 6 S.E.M. *** P,0.001.
doi:10.1371/journal.pone.0008698.g003
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compared with paxilline is also seen for their motor function
effects [48,9]. This delay, however, does not occur in macropatch
recordings [30,9,31], suggesting that it relates to the ability of these
compounds to access their binding sites in vivo.
Experiments using beta subunit knock-out mice strongly
suggests that neither b1 nor b4 accessory subunits are required
for paxilline to affect heart rate. This suggests that the bradycardia
produced by these compounds is unlikely to be due to secondary
vascular effects or neural regulation, since b1o rb4 subunits are
required for the calcium-mediated vascular and neural effects,
respectively. Sensitivity to iberiotoxin is greatly reduced in neural
BK channels co-assembled with b4 subunits [27,28]. The fact that
iberiotoxin was able to decrease heart rate significantly in the
isolated heart suggests that this effect at least partially involves BK
channels that lack b4 subunits. Preliminary experiments conduct-
ed in the presence of the cholinergic antagonist atropine (3 mM)
showed no change in the bradycardic effect of paxilline (1 mM)
(data not shown). Atropine would limit any residual vagal
cholinergic influence on the pacemaker that might decrease
heart rate. While this preliminary observation suggests that
autonomic involvement is unlikely, this possibility requires further
investigation.
BK channels in coronary arterioles are a possible site of action
for the inhibitors. However, coronary flow remained constant
throughout the isolated rat heart experiments, indicating that
coronary resistance was constant, and therefore vasoconstriction
did not occur. Furthermore, potent vasoconstrictors have little or
no effect on heart rate in the isolated heart [55,56,57], suggesting
that any inhibition of BK channels in coronary blood vessels would
be unlikely to make a substantial contribution to the observed
bradycardia.
A pacemaker location for BK channels is a possibility that
would enable direct regulation of heart rate. Although ion channel
expression in the mouse pacemaker has been thoroughly
investigated, no studies have examined BK expression in sinoatrial
node (SAN) cells [58,41]. BK channel mRNA expression has been
quantified in the whole heart, but only low levels have been
detected [38,21,40]. If BK channels are expressed solely in
pacemaker cells, this might account for the low level of expression
when the whole heart is examined, as the signal would be greatly
diluted. Expression of BK channels at this site could easily go
undetected because of the small area involved and difficulty in
identifying the exact region where the SAN cells are located. From
a pacemaker location BK channels might influence heart rate by
modulating action potential firing and repolarisation. Alternative-
ly, if BK channels are present in SAN cell mitochondria,
their inhibition might influence heart rate through metabolic
mechanisms.
It may seem surprising that chronotropic effects of BK channel
inhibitors have not been reported previously. Several studies have
examined paxilline effects in an isolated heart in the context of
ischemia/reperfusion [17,59,60], but none examined the effect of
paxilline on heart rate. Our study is the first to have examined the
effect of BK channel inhibitors on heart rate by monitoring drug
effects within animals, and in the isolated heart, using a range of
paxilline concentrations. This may explain why we were able to
observe a bradycardic effect that has not been previously reported.
The results presented in this study support the hypothesis that
BK channels are expressed and functional in the heart. Their
tissue location and role in cellular excitability remain to be
determined. The bradycardic effects that BK channel inhibitors
have on heart rate suggests that these channels could be potential
targets for pharmacological modulation of heart rate for medicinal
purposes, such as in hypertension, or during surgery.
Supporting Information
Figure S1 Comparison of peak effect of indole diterpene
compounds on heart rate and blood pressure in wild-type mice.
The effect of 8 mg/kg paxilline (pax), 4 mg/kg lolitrem B (lol B),
8 mg/kg lolitrem E acetate (lol E ac), 20 mg/kg 31-epilolitrem B
(31-epilol B), and DMSO controls, in wild-type mice on: (A) heart
rate, and (B) blood pressure. Significance was tested using least
significant difference post hoc test after analysis of variance. All
data are mean 6 S.E.M. *** P,0.001.
Found at: doi:10.1371/journal.pone.0008698.s001 (4.85 MB TIF)
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